J.W. Coons Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$322K Hold
600
0.07% 196
2025
Q1
$252K Hold
600
0.07% 209
2024
Q4
$248K Hold
600
0.06% 210
2024
Q3
$303K Hold
600
0.08% 197
2024
Q2
$292K Hold
600
0.07% 195
2024
Q1
$324K Hold
600
0.07% 189
2023
Q4
$333K Hold
600
0.09% 179
2023
Q3
$262K Hold
600
0.08% 198
2023
Q2
$301K Hold
600
0.08% 194
2023
Q1
$300K Hold
600
0.09% 192
2022
Q4
$245K Sell
600
-21
-3% -$8.15K 0.07% 206
2022
Q3
$202K Hold
621
0.08% 205
2022
Q2
$218K Sell
621
-79
-11% -$32.2K 0.08% 226
2022
Q1
$396K Buy
700
+30
+4% +$15.8K 0.12% 173
2021
Q4
$443K Sell
670
-115
-15% -$72.2K 0.13% 160
2021
Q3
$488K Buy
785
+106
+16% +$71.2K 0.17% 143
2021
Q2
$429K Sell
679
-111
-14% -$61.3K 0.15% 149
2021
Q1
$385K Buy
790
+95
+14% +$47.6K 0.14% 156
2020
Q4
$347K Hold
695
0.13% 151
2020
Q3
$273K Sell
695
-55
-7% -$20.3K 0.11% 161
2020
Q2
$249K Buy
+750
New +$217K 0.11% 166

Other funds holding IDXX

J.W. Coons Advisors's IDXX Position: Q2 2025 in Review

J.W. Coons Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2025 at 600 shares worth $322K. The position accounts for 0.07% of the portfolio, ranked #196.

J.W. Coons Advisors first reported a position in IDXX in Q2 2020 and has held it in 21 quarters since. The position peaked at $488K in Q3 2021. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • J.W. Coons Advisors held 600 shares of Idexx Laboratories worth $322K as of Q2 2025.
  • J.W. Coons Advisors left its Idexx Laboratories share count unchanged in Q2 2025.
  • Idexx Laboratories made up 0.07% of J.W. Coons Advisors's portfolio in Q2 2025, its #196 holding.
  • J.W. Coons Advisors first reported a position in Idexx Laboratories in Q2 2020 and has held it in 21 quarters since.
  • J.W. Coons Advisors's Idexx Laboratories position peaked at $488K in Q3 2021.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.